Short Interest in Senestech, Inc. (NASDAQ:SNES) Grows By 181.6%

Senestech, Inc. (NASDAQ:SNES) was the recipient of a significant increase in short interest in the month of January. As of January 30th, there was short interest totaling 36,090 shares, an increase of 181.6% from the January 15th total of 12,817 shares. Based on an average daily trading volume, of 44,177 shares, the short-interest ratio is currently 0.8 days. Approximately 0.7% of the shares of the stock are short sold. Approximately 0.7% of the shares of the stock are short sold. Based on an average daily trading volume, of 44,177 shares, the short-interest ratio is currently 0.8 days.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Senestech in a report on Monday, December 29th. One analyst has rated the stock with a Strong Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold”.

Senestech Stock Performance

Shares of SNES opened at $1.78 on Friday. Senestech has a 12-month low of $1.30 and a 12-month high of $6.24. The company has a current ratio of 15.75, a quick ratio of 14.73 and a debt-to-equity ratio of 0.01. The company has a market cap of $9.29 million, a PE ratio of -0.49 and a beta of 0.21. The stock has a 50-day moving average price of $2.19 and a 200-day moving average price of $3.44.

Senestech (NASDAQ:SNES) last announced its earnings results on Monday, November 10th. The company reported ($0.28) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.35) by $0.07. Senestech had a negative net margin of 253.54% and a negative return on equity of 98.35%. The business had revenue of $0.69 million for the quarter, compared to the consensus estimate of $0.73 million. As a group, equities analysts forecast that Senestech will post -10.22 earnings per share for the current fiscal year.

Insider Activity

In other news, major shareholder Glenbrook Capital Management acquired 42,739 shares of the business’s stock in a transaction dated Monday, February 2nd. The stock was bought at an average cost of $1.98 per share, for a total transaction of $84,623.22. Following the completion of the transaction, the insider owned 593,785 shares of the company’s stock, valued at $1,175,694.30. The trade was a 7.76% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Insiders have bought 56,707 shares of company stock valued at $110,171 over the last quarter. Corporate insiders own 5.29% of the company’s stock.

Institutional Investors Weigh In On Senestech

A number of large investors have recently added to or reduced their stakes in the company. Jane Street Group LLC bought a new stake in Senestech during the fourth quarter worth about $32,000. DRW Securities LLC raised its holdings in shares of Senestech by 171.1% during the 4th quarter. DRW Securities LLC now owns 82,107 shares of the company’s stock valued at $176,000 after buying an additional 51,818 shares in the last quarter. Renaissance Technologies LLC lifted its position in Senestech by 35.2% in the 4th quarter. Renaissance Technologies LLC now owns 142,800 shares of the company’s stock worth $306,000 after buying an additional 37,165 shares during the last quarter. Diversify Advisory Services LLC purchased a new stake in Senestech in the fourth quarter worth approximately $34,000. Finally, Millennium Management LLC bought a new position in Senestech during the third quarter valued at approximately $126,000. Hedge funds and other institutional investors own 5.19% of the company’s stock.

About Senestech

SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.

The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.